Ken Griffin Drug Manufacturers—Specialty & Generic

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025

Stock List

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$12.3B
$258 Million 0.05% of portfolio
2,049,075
Q2 2025 Added 130.48%
$8.26B
$196 Million 0.04% of portfolio
13,700,781
Q2 2025 Added 99.53%
$70.1B
$111 Million 0.02% of portfolio
710,816
Q2 2025 Added 754.49%
$12.3B
$66.3 Million 0.01% of portfolio
7,429,372
Q2 2025 Added 20.76%
$44.5B
$47.4 Million 0.01% of portfolio
4,570,800
Q2 2025 Reduced 23.56%
$1.37B
$45.5 Million 0.01% of portfolio
5,624,682
Q2 2025 Reduced 24.92%
$1.54B
$37.2 Million 0.01% of portfolio
569,630
Q2 2025 Reduced 21.25%
$18.4B
$37.1 Million 0.01% of portfolio
2,213,086
Q2 2025 Reduced 22.43%
$943M
$20.4 Million 0.0% of portfolio
668,642
Q2 2025 Added 143.82%
$3.71B
$19.4 Million 0.0% of portfolio
237,067
Q2 2025 Added 44.6%
$3.1B
$10.8 Million 0.0% of portfolio
405,143
Q2 2025 Reduced 78.04%
$679M
$9.09 Million 0.0% of portfolio
1,394,495
Q2 2025 Added 20.13%
$1.29B
$7.1 Million 0.0% of portfolio
240,156
Q2 2025 Reduced 52.92%
$1.49B
$6.71 Million 0.0% of portfolio
292,345
Q2 2025 Added 87.43%
$1.34B
$5.87 Million 0.0% of portfolio
591,960
Q2 2025 Reduced 1.83%
$2.21B
$5.52 Million 0.0% of portfolio
175,134
Q2 2025 Added 8.43%
$604M
$4.29 Million 0.0% of portfolio
168,142
Q2 2025 New
$119M
$2.28 Million 0.0% of portfolio
2,329,133
Q2 2025 Added 11.38%
$581M
$2.28 Million 0.0% of portfolio
5,553,958
Q2 2025 Added 1,667.9%
$444M
$1.8 Million 0.0% of portfolio
281,501
Q2 2025 Reduced 4.55%
$2.31B
$1.51 Million 0.0% of portfolio
100,202
Q2 2025 Reduced 37.2%
$967M
$1.25 Million 0.0% of portfolio
656,216
Q2 2025 Added 799.89%
$4.49B
$1.07 Million 0.0% of portfolio
37,423
Q2 2025 Reduced 55.64%
$797M
$987,000 0.0% of portfolio
101,885
Q2 2025 Reduced 4.45%
$2.65B
$563,000 0.0% of portfolio
37,411
Q2 2025 Added 632.83%
$0
$521,000 0.0% of portfolio
40,326
Q2 2025 New
$202M
$503,000 0.0% of portfolio
152,156
Q2 2025 Reduced 66.89%
$593M
$368,000 0.0% of portfolio
100,779
Q2 2025 Reduced 57.43%
$335M
$258,000 0.0% of portfolio
33,378
Q2 2025 Reduced 47.34%
$42.7M
$249,000 0.0% of portfolio
74,406
Q2 2025 Added 188.24%
$150M
$222,000 0.0% of portfolio
309,272
Q2 2025 Reduced 67.12%
$40M
$184,000 0.0% of portfolio
288,838
Q2 2025 Added 139.68%
$134M
$171,000 0.0% of portfolio
34,988
Q2 2025 Added 63.33%
$2.53B
$145,000 0.0% of portfolio
21,820
Q2 2025 Reduced 98.27%
$1.35B
$141,000 0.0% of portfolio
33,574
Q2 2025 New
$78.1M
$60,000 0.0% of portfolio
41,068
Q2 2025 Reduced 2.95%
$0
$4,000 0.0% of portfolio
20,415
Q2 2025 Reduced 33.16%
$0
$0 0.0% of portfolio
29,389
Q2 2025 Reduced 3.72%
Filter Shares Options
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email